tirzepatide cv outcomes trial A comparison of the effects of and dulaglutide on major kidney events in people with type 2 diabetes: pre-specified exploratory analyses of the SURPASS-CVOT American - SUMMIT trial results
Description
Phase 1: initiation dose (2.5mg, weeks 1 through 4) At this stage, appetite suppression is mild to moderate
Semaglutide (Wegovy, Ozempic) Semaglutide is the most established alternative and the one most people consider first

But instead of pairing GLP-1 with GIP, survodutide pairs GLP-1 with the glucagon receptor

Tirzepatide in its lyophilized form should appear as a white to off-white powder
